诺和诺德 NVO 深 沪
等待开盘 03-27 09:30:00 美东时间
36.40
+0.070
+0.19%
华盛通- 最 高37.44
- 今 开36.29
- 成交量 2059.97万股
- 最 低 36.1301
- 昨 收 36.33
- 总市值 1625.26亿
- 52周最高 81.0284
- 市盈率 静 10.45
- 换手率 0.46%
- 52周最低 35.85
- 委 比 44.58%
- 总股本 44.65亿
- 历史最高 146.557
- 量 比 1.08
- 振 幅 3.61%
- 历史最低 9.5975
- 每 手 1
- 风险率 10.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股机会日报 | 伊朗放话已关闭霍尔木兹海峡！国际油价应声走高；特朗普何时结束战争？巴克莱点出“五大关键信号”
局势再升温！伊朗警告已关闭霍尔木兹海峡，国际油价应声走高；抢先入场！美资管公司拟推出2倍做多SpaceX和Anthropic的ETF；特朗普何时结束战争？巴克莱点出“五大关键信号”>>
13分钟前
Novo Nordisk Wins FDA Nod For First-Ever Weekly Basal Insulin
FDA approves Novo Nordisk once-weekly insulin Awiqli for Type 2 diabetes, offering an alternative to daily injections.
48分钟前
司美格鲁肽生产商称AI智能体正在缩短其临床试验周期
在竞争极度激烈的药物研发领域，一款新药能否尽快上市，会对商业结果产生重大影响。近期最典型的例子莫过于诺和诺德：该公司旗下减重药物司美格鲁肽（Ozempic...
今天 18:04
What's Happening With Novo Nordisk Stock Today?
Novo Nordisk A/S (NYSE:NVO) shares are moving higher on Thursday. Hims & Hers Health Inc (NYSE:HIMS) announced it will begin offering several of the Novo's FDA‑approved GLP‑1 medications, including the newly launched Wegovy pill.
今天 01:47
Hims & Hers Health starts selling Novo Nordisk's Wegovy, Ozempic
Hims & Hers Health (HIMS) said that it has begun selling Novo Nordisk (NVO) GLP-1 medicines Wegovy (semaglutide) and Ozempic (semaglutide), which are indicated for weight loss and type 2 diabetes. All...
今天 00:44
Novo Nordisk adds Mars CEO as board observer
In its annual general meeting on Thursday, Novo Nordisk (NVO) announced the appointment of Poul Weihrauch, CEO of U.S. chocolate maker Mars, as an observer to the weight-loss drugmaker’s board. The fo...
03-26 23:57
Novo Nordisk picks Mars CEO as board observer
Novo Nordisk picks Mars CEO as board observer COPENHAGEN, March 26 (Reuters) - Novo Nordisk NOVOb.CO said on Thursday it would nominate Poul Weihrauch, CEO of chocolate maker Mars, as observer to its board, as the drugmaker tries to regain a stronger footing in the competitive U.S. obesity market. (
03-26 22:37
